Literature DB >> 23806156

Bullous pemphigoid: etiology, pathogenesis, and inducing factors: facts and controversies.

Ada Lo Schiavo1, Eleonora Ruocco2, Gabriella Brancaccio2, Stefano Caccavale2, Vincenzo Ruocco2, Ronni Wolf3.   

Abstract

The term pemphigoids includes a group of autoimmune bullous diseases characterized by subepidermal blistering. Bullous pemphigoid (BP) is not only the most common disorder within the pemphigoid group, but also represents the most frequent autoimmune blistering disease in general. The onset and course of BP depend on a variable interaction between predisposing and inducing factors. HLA genes are the most significant genetic predisposition factor to autoimmunity mechanisms. Many studies show an association between HLA-DQβ1*0301 and distinct clinical pemphigoid variants. Imbalance between autoreactive T helper (Th) and T regulatory cells, toll-like receptor activation, and Th17/IL-17 pathway are the three possible autoimmunity triggers underlying BP. The pathomechanism of BP hinges on an autoantibody response toward structural components of the hemidesmosome (BP180 and BP230). The binding of autoantibodies leads to complement activation, recruitment of inflammatory cells, and release of proteolytic enzymes. The inflammatory cascade also may be directly triggered by activation of Th17 cells with no intervention of autoantibodies. The intervention of inducing factors in BP can be identified in no more than 15% of patients. Facilitating factors in genetically predisposed individuals are various (drug intake, physical agents, and viral infections). Drugs may act as triggers by either modifying the immune response or altering the antigenic properties of the epidermal basement membrane. Cases of induction of BP by physical agents (eg, radiation therapy, ultraviolet radiation, thermal or electrical burns, surgical procedures, transplants) are rare, but well-documented events. A contributing role in inducing BP has been suggested for infections, in particular human herpes virus (HHV) infections (cytomegalovirus, Epstein-Barr virus, and HHV-6), but also hepatitis B and C viruses, Helicobacter pylori, and Toxoplasma gondii. Unlike pemphigus, no dietary triggers have been suspected of being involved in the induction of BP. In all patients who have a diagnosis of BP, an environmental agent as a potential cause should always be considered, because the prompt discontinuation of it might result in rapid improvement or even cure of the disease.
Copyright © 2013. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23806156     DOI: 10.1016/j.clindermatol.2013.01.006

Source DB:  PubMed          Journal:  Clin Dermatol        ISSN: 0738-081X            Impact factor:   3.541


  45 in total

1.  Bullous pemphigoid in infant post vaccination: Myth or reality?

Authors:  Iria Neri; Antonella Greco; Andrea Bassi; Jacinto Orgaz-Molina; Riccardo Balestri; Teresa Oranges; Annalisa Patrizi; Maurizio de Martino
Journal:  Int J Immunopathol Pharmacol       Date:  2015-12-18       Impact factor: 3.219

2.  Lisinopril-associated bullous pemphigoid in an elderly woman: a case report of a rare adverse drug reaction.

Authors:  Rami A Ballout; Umayya Musharrafieh; Joe Khattar
Journal:  Br J Clin Pharmacol       Date:  2018-08-29       Impact factor: 4.335

3.  Aberrant expression and altered cellular localization of desmosomal and hemidesmosomal proteins are associated with aggressive clinicopathological features of oral squamous cell carcinoma.

Authors:  Zhao Xin; Akira Yamaguchi; Kei Sakamoto
Journal:  Virchows Arch       Date:  2014-05-22       Impact factor: 4.064

Review 4.  Bullous pemphigoid: An immune disorder related to aging (Review).

Authors:  Maria Ludovica Deotto; Alice Spiller; Alvise Sernicola; Mauro Alaibac
Journal:  Exp Ther Med       Date:  2021-11-15       Impact factor: 2.447

Review 5.  Helicobacter pylori and skin autoimmune diseases.

Authors:  Eli Magen; Jorge-Shmuel Delgado
Journal:  World J Gastroenterol       Date:  2014-02-14       Impact factor: 5.742

6.  Bullous pemphigoid caused by contact allergy to bone cement: A case report.

Authors:  Sylvie M Franken; Thomas Rustemeyer
Journal:  Contact Dermatitis       Date:  2020-12-27       Impact factor: 6.600

Review 7.  Bullous Pemphigoid Associated with Anti-programmed Cell Death Protein 1 and Anti-programmed Cell Death Ligand 1 Therapy: A Review of the Literature.

Authors:  Aikaterini Tsiogka; Johann W Bauer; Aikaterini Patsatsi
Journal:  Acta Derm Venereol       Date:  2021-01-20       Impact factor: 3.875

8.  Bullous pemphigoid and neurological disease: statistics from a dermatology service.

Authors:  Monica Jidid Mateus Tarazona; Amanda Nascimento Cavalleiro de Macedo Mota; Alexandre Carlos Gripp; Natasha Unterstell; Aline Lopes Bressan
Journal:  An Bras Dermatol       Date:  2015 Mar-Apr       Impact factor: 1.896

9.  Tube shunt coverage with gamma-irradiated cornea allograft (VisionGraft).

Authors:  Feyzahan Ekici; Marlene R Moster; Victor Cvintal; Wanda D Hu; Michael Waisbourd
Journal:  Clin Ophthalmol       Date:  2015-05-04

10.  Activation of Blood Coagulation in Two Prototypic Autoimmune Skin Diseases: A Possible Link with Thrombotic Risk.

Authors:  Massimo Cugno; Alberto Tedeschi; Alessandro Borghi; Paolo Bucciarelli; Riccardo Asero; Luigia Venegoni; Samantha Griffini; Elena Grovetti; Emilio Berti; Angelo Valerio Marzano
Journal:  PLoS One       Date:  2015-06-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.